Nanlin Li

608 total citations
28 papers, 493 citations indexed

About

Nanlin Li is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Nanlin Li has authored 28 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Nanlin Li's work include HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers) and Microstructure and mechanical properties (4 papers). Nanlin Li is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers) and Microstructure and mechanical properties (4 papers). Nanlin Li collaborates with scholars based in China and United States. Nanlin Li's co-authors include Wen‐Ping Wu, Yun-Li Li, Rui Ling, Xiangwei Kong, Ruidong Ye, Qianzi Yang, Shifang Yuan, Junliang Han, Jianghao Chen and Jing Fan and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Critical Care Medicine.

In The Last Decade

Nanlin Li

27 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanlin Li China	13	196	128	87	79	51	28	493
Kuan Zhang China	12	474 2.4×	50 0.4×	77 0.9×	15 0.2×	37 0.7×	21	748
Katsuhiko Masamura Japan	13	140 0.7×	60 0.5×	125 1.4×	110 1.4×	36 0.7×	19	537
Tetsuya Takada Japan	9	182 0.9×	47 0.4×	32 0.4×	16 0.2×	24 0.5×	24	458
Ching-Hsin Ku United Kingdom	6	208 1.1×	64 0.5×	83 1.0×	39 0.5×	19 0.4×	6	472
Tong Ge China	11	139 0.7×	76 0.6×	28 0.3×	157 2.0×	57 1.1×	16	520
Keiko Takata Japan	12	113 0.6×	44 0.3×	122 1.4×	74 0.9×	43 0.8×	15	495
Zongjie Wei China	11	173 0.9×	91 0.7×	15 0.2×	10 0.1×	25 0.5×	24	385
Jinpin Li China	14	328 1.7×	268 2.1×	14 0.2×	36 0.5×	18 0.4×	26	520
Xiaofei Wang China	14	118 0.6×	74 0.6×	17 0.2×	7 0.1×	59 1.2×	50	553

Countries citing papers authored by Nanlin Li

Since Specialization

Citations

This map shows the geographic impact of Nanlin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanlin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanlin Li more than expected).

Fields of papers citing papers by Nanlin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanlin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanlin Li. The network helps show where Nanlin Li may publish in the future.

Co-authorship network of co-authors of Nanlin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Nanlin Li. A scholar is included among the top collaborators of Nanlin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanlin Li. Nanlin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Jiang, Yuqing Yang, Xinxin Wen, et al.. (2024). A historical controlled study of domestic trastuzumab and pertuzumab in combination with docetaxel for the neoadjuvant treatment of early HER2-positive breast cancer. Frontiers in Oncology. 14. 1281643–1281643. 2 indexed citations

Hu, Wenyu, et al.. (2023). Research Status of Systemic Adjuvant Therapy for Early Breast Cancer. Cancer Control. 30. 2915627241–2915627241. 4 indexed citations

Yang, Jixin, Yuqing Yang, Wen‐Yu Hu, et al.. (2023). A Phase II Study of Neoadjuvant PLD/Cyclophosphamide and Sequentialnab-Paclitaxel Plus Dual HER2 Blockade in HER2-Positive Breast Cancer. The Oncologist. 29(1). e15–e24. 5 indexed citations

Hu, Wen‐Yu, et al.. (2023). Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis. Translational Cancer Research. 12(2). 247–256. 8 indexed citations

Zhao, Bing, Xiaoling Ling, Donghui Li, et al.. (2023). Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China. BMC Cancer. 23(1). 103–103. 5 indexed citations

Li, Fanfan, Cong Gao, Jingjing Li, et al.. (2022). Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab. Frontiers in Oncology. 12. 819818–819818. 6 indexed citations

Yuqing, Yang, Lei Wang, Jingjing Xiao, et al.. (2019). Clinical significance of 21-gene recurrence score assay for hormone receptor–positive, lymph node-negative breast cancer in early stage. Experimental and Molecular Pathology. 108. 150–155. 4 indexed citations

Wang, Zhe, Jing Kong, Ying Wu, et al.. (2017). PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer. Breast Cancer Research and Treatment. 168(2). 531–542. 44 indexed citations

Li, Nanlin, Jipeng Li, Jing Fan, et al.. (2017). Immediate breast reconstruction with omental flap for luminal breast cancer patients. Medicine. 96(33). e7797–e7797. 8 indexed citations

10.

Wu, Jiang, Weizhi Li, Meiling Huang, et al.. (2017). Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells. Biochemical and Biophysical Research Communications. 483(1). 10–16. 26 indexed citations

11.

Li, Yongping, Guohong Cai, Shifang Yuan, et al.. (2015). The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.. PubMed. 7(1). 120–7. 16 indexed citations

12.

Wang, Hui, Lei Wang, Zheng Wu, et al.. (2014). Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. Medical Oncology. 31(12). 298–298. 61 indexed citations

13.

Chen, Tao, Ning Lin, Hong-tao Yan, et al.. (2014). Ultrasound-guided double-tract percutaneous cholecystostomy combined with a choledochoscope for performing cholecystolithotomies in high-risk surgical patients. Surgical Endoscopy. 28(7). 2236–2242. 2 indexed citations

14.

Wang, Tao, Tao Chen, Hong-tao Yan, et al.. (2014). Notch inhibition promotes fetal liver stem/progenitor cells differentiation into hepatocytes via the inhibition of HNF-1β. Cell and Tissue Research. 357(1). 173–184. 12 indexed citations

15.

Wang, Hui, Lei Wang, Nanlin Li, et al.. (2014). Subanesthetic Isoflurane Reduces Zymosan-Induced Inflammation in Murine Kupffer Cells by Inhibiting ROS-Activated p38 MAPK/NF-κB Signaling. Oxidative Medicine and Cellular Longevity. 2014. 1–13. 42 indexed citations

16.

Wang, Hui, Jing Fan, Nanlin Li, et al.. (2013). A Subanesthetic Dose of Isoflurane during Postconditioning Ameliorates Zymosan-Induced Neutrophil Inflammation Lung Injury and Mortality in Mice. Mediators of Inflammation. 2013. 1–14. 17 indexed citations

17.

Huang, Chen, Yonggang Lv, Peng Zhāng, et al.. (2012). An atypical patient with 2009 influenza (H1N1) infection and multiple organ dysfunctions. African Journal of Microbiology Research. 6(45). 7237–7240. 1 indexed citations

18.

Ye, Ruidong, Qianzi Yang, Xiangwei Kong, et al.. (2012). Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia. Critical Care Medicine. 40(9). 2685–2693. 55 indexed citations

19.

Xue, Yan, et al.. (2011). Phosphatidylinositol 3′-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1α and vascular endothelial growth factor expression. American Journal of Physiology-Heart and Circulatory Physiology. 300(6). H2169–H2176. 20 indexed citations

20.

Dong, Wenpeng, Dakuan Gao, Hong Lin, et al.. (2007). New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9. Medical Hypotheses. 70(1). 52–55. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact